February 25, 2020 07:04 AM ESTUpdated 08:18 AM

Mallinckrodt, once the nation’s largest oxycodone producer, announces tentative $1.6B settlement

Jason Mast

Editor

Three years after it first paid out fines for its role in the US opioid abuse epidemic, Mallinckrodt has announced an agreement-in-principle that will see …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Mallinckrodt, once the nation’s largest oxycodone producer, announces tentative $1.6B settlement

Jason Mast

Editor

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

Boehringer’s updated results in HER2-mutated lung cancer impress

Novavax responds to FDA’s trial ask, with Covid vaccine strain updates under scrutiny

GSK’s checkpoint blocker Jemperli cures biomarker-driven rectal cancer

Merck KGaA to buy rare cancer biotech SpringWorks for $3.9B

Scholar Rock names new CEO, adds biotech veterans in C-suite rebuild

Revolutionizing obesity treatment: Could mitochondria hold the key to unlocking fat-specific weight loss?

Mallinck­rodt, once the na­tion’s largest oxy­codone pro­duc­er, an­nounces ten­ta­tive $1.6B set­tle­ment

Editor

Sign up to read this article for free.

Celldex Therapeutics

Hampton, NJ, USA

Mallinckrodt, once the nation’s largest oxycodone producer, announces tentative $1.6B settlement